Strategic Reset: Health System's Critical Window to Act During the 90-Day Tariff Truce - Black Book Research

April 9, 2025 4:45 PM

In response to President Donald Trump's April 9 announcement pausing most new U.S. import tariffs for 90 days, Black Book Research has issued targeted guidance for healthcare CFOs, procurement executives, and strategic sourcing leaders. With elevated tariffs still anticipated on pharmaceuticals, medical devices, and healthcare IT infrastructure, this temporary reprieve provides a critical window for organizations to recalibrate cost structures,...

Read more

Bionic Bloom Presents: Cannadelic Miami 2025 Announces Featured Speaker - Laura Hartman

April 9, 2025 2:00 PM

Bionic Bloom, the nation's first legal psilocybin therapy center and Title Sponsor of Cannadelic Miami 2025, is honored to announce Laura Hartman, BSN, BC-FMP, a distinguished cannabis nurse and board-certified functional medicine practitioner, as a featured speaker at this year's conference. Cannadelic Miami 2025 is scheduled for May 23-24, 2025, at the Miami Airport Convention Center.​Laura Hartman brings a wealth of experience in functional...

Read more

A New Era of Healthcare: Desert Oasis Healthcare Unveils Cutting-Edge AI Solutions

April 9, 2025 1:00 PM

Desert Oasis Healthcare (DOHC) is proud to announce its pioneering use of artificial intelligence (AI) to enhance healthcare services for both patients and providers. As a leader in innovation, DOHC is leveraging cutting-edge AI technologies to ensure the highest quality of care, improve efficiency, and meet the growing demand for healthcare in the Coachella Valley.The healthcare industry is facing a significant challenge-there simply aren't...

Read more

Helen’s Pink Sky Foundation Launches to Accelerate Research for Batten Disease and Provide Support to Affected Families

April 9, 2025 11:25 AM

Today, the Born and Schneider family announced the launch of Helen's Pink Sky Foundation, a new nonprofit dedicated to accelerating research, raising awareness, and improving the lives of those affected by Batten disease. The foundation is committed to funding groundbreaking research aimed at both finding a cure for Batten disease and supporting patients and their families with essential resources.Batten disease is a rare, genetically inherited...

Read more

Groundbreaking Study on Risk Assessment of Breast Cancer Aims to Revolutionize Diagnosis and Treatment

April 9, 2025 10:00 AM

CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breast cancer risk assessment test and diagnostic tools, today announced it is expanding its patient study research on targeted breast cancer biomarkers for risk assessment leading to early detection.A new study directed by CYduct Diagnostics, Inc. is set to transform the landscape of breast cancer...

Read more

Advancements in Consumer-Centric Patient Engagement and Communication Solutions: 2025 Report by Black Book

April 9, 2025 9:45 AM

Black Book Market Research LLC, the healthcare industry's leading independent research firm, has released its highly anticipated 2025 Black Book of Patient Engagement & Healthcare Consumer Communications Technology. This comprehensive report, now available for free download at Black Book Market Research, provides an in-depth analysis of the tools, technologies, and strategies shaping the future of patient engagement and healthcare consumer...

Read more

NCQA Issues Health Care Recommendations for the Trump Administration

April 9, 2025 9:15 AM

The National Committee for Quality Assurance (NCQA) today released recommendations for the Trump Administration and the 119th Congress to build a more transparent, integrated and interoperable health care system. The National Committee for Quality Assurance: Recommendations for the Trump Administration outlines a vision for evolving the current U.S. quality measurement ecosystem to support patient-driven, cost-effective, integrated care and...

Read more

SpendMend Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

April 9, 2025 9:00 AM

SpendMend, a leading provider of cost cycle management solutions to the healthcare industry, today announced that its systems-Analytics, Data Capture & Processing System, Data Storage System, Medical Device Warranty Tracking (MDWT), Portal, Rebate Insight, Trulla Direct, and Trulla Procurement-have earned HITRUST i1 Certified status for information security.HITRUST i1 Certification demonstrates that these systems are leveraging a curated set of...

Read more

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 9, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral transmucosal fast-acting high-dose aspirin formulation.One clinical trial site has been activated with patient enrollment expected to total six to eight participants and begin during...

Read more

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

April 9, 2025 8:00 AM

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical Alliance (pCPA) for Canadian public drug plan coverage for PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, a new triple-combination topical prescription treatment for acne vulgaris in patients 12 years of age and...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Increases Guidance by 30% to More than $65M in 2025 Pro Forma Revenue

April 9, 2025 7:10 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today raised 2025 pro forma revenue by 30% to more than $65M in the updated investor presentation published on its investor website.The presentation also provides more details on its recently-announced binding agreement to acquire Wattbike, the...

Read more

New Mexico Governor Signs Bill Allowing for Psilocybin Use

April 9, 2025 6:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that New Mexico governor Michelle Lujan signed SB 219, the Medical Psilocybin Act, which will establish the third state-legal psilocybin access system in the United States.The Medical Psilocybin Act will provide patients with specific qualifying conditions to obtain the psychedelic and to use it...

Read more

DEA’s Marijuana Double Standard: Attorney Aarathi Haig Flouts Ethics Laws While Blocking MMJ's Cannabis Research

April 9, 2025 5:00 AM

The United States Drug Enforcement Administration (DEA), the federal agency tasked with enforcing the nation's controlled substances laws, now finds itself in the center of a growing controversy that threatens its credibility. The issue isn't just about the bureaucratic delays that have stalled vital medical marijuana research, it's about the integrity of the individuals charged with upholding the law. Aarathi Haig, the DEA attorney...

Read more

Bionic Bloom Presents: Cannadelic Miami 2025 Announces Featured Speaker—Ricky Williams

April 9, 2025 5:00 AM

Bionic Bloom, the nation's first legal psilocybin therapy center and Title Sponsor of Cannadelic Miami 2025, is honored to announce Ricky Williams, former NFL star and founder of the cannabis lifestyle brand Highsman, as a featured speaker at this year's conference. Cannadelic Miami 2025 is scheduled for May 23-24, 2025, at the Miami Airport Convention Center.​Ricky Williams, renowned for his illustrious football career and advocacy for cannabis...

Read more

Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)

April 9, 2025 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)This English version of the notice to the Annual General Meeting is for convenience only. The Swedish version prevails in the event of any inconsistency.The shareholders of Spago Nanomedical AB (publ), corporate registration number 556574-5048 are hereby summoned to the Annual General Meeting on Wednesday 14 May 2025, at 13.00 p.m. CEST at Advokatfirman Cederquist's premises, Hovslagargatan 3, in...

Read more

Notice to Annual General Meeting in AlzeCure Pharma AB

April 9, 2025 2:20 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB, reg. no. 559094-8302 (the "Company") are hereby invited to attend the annual general meeting to be held on Wednesday 14 May 2025 at 4 p.m. CET at Synch Advokat AB's premises at Birger Jarlsgatan 6, in Stockholm.REGISTRATION AND NOTIFICATIONShareholders who wish to attend the annual general meeting shall;i. be recorded in the share register maintained by Euroclear...

Read more

Bionic Bloom Presents: Cannadelic Miami 2025

April 8, 2025 5:00 PM

Bionic Bloom, the nation's first legal psilocybin therapy center and Title Sponsor of Cannadelic Miami 2025, is honored to announce Paul Karasik, CEO of The Psychedelic Institute of Los Angeles, as a featured speaker at this year's conference. Cannadelic Miami 2025 is scheduled for May 23-24, 2025, at the Miami Airport Convention Center.​Paul Karasik is a distinguished figure in the psychedelic community, known for his extensive contributions to...

Read more

Ascelia Pharma Announces Publication of Orviglance Study in Investigative Radiology

April 8, 2025 4:20 PM

Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the publication of a scientific article in the journal Investigative Radiology. The article features its orphan drug candidate Orviglance® in a comparison study to unenhanced MRI and to gadolinium.The publication titled ‘Lesion Visualization of an Oral Manganese Contrast Agent...

Read more

CORRECTION: Ondine Biomedical Inc. Announces Steriwave in first Swiss hospital

April 8, 2025 1:15 PM

Ondine Biomedical Inc. (LON:OBI) reports that University Hospital Zurich (USZ) has initiated an independent clinical study evaluating Steriwave®. This marks the first Swiss deployment of Ondine's nasal decolonization technology to combat surgical site infections (SSI).The study, titled "Preoperative Microbial Reduction of the Nasal Cavity with Antimicrobial Photodynamic Therapy (aPDT)," is led by Professor Dr. Dr. Harald Essig, Head of the...

Read more

Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis of Substance Use Disorder

April 8, 2025 1:00 PM

Ignite Biomedical, Inc. ("Ignite"), a leader in AI-driven biomarker innovation for precision medicine, along with Liquid Biosciences ("Liquid"), today announced the discovery of biomarkers to diagnose substance use disorder (SUD). This achievement underscores Ignite's ability to leverage their technology to expand into areas of medicine beyond inflammatory disease, while maintaining their focus on those disease states with a tremendous unmet...

Read more